F
Fennec Pharmaceuticals Inc
F:RV41
Fennec Pharmaceuticals Inc
F:RV41
Price:
5.75
EUR
-4.96%
Market Cap:
€157.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
F
|
Fennec Pharmaceuticals Inc
F:RV41
|
US |
|
V
|
Veeva Systems Inc
F:VEE
|
US |
|
B
|
Bayerische Motoren Werke AG
XHAM:BMW
|
DE |
|
Young & Co's Brewery PLC
OTC:YCSBF
|
UK |
|
N
|
Nestle SA
SWB:NESM
|
CH |
|
ING Groep NV
MIL:1INGA
|
NL |
|
MAG Silver Corp
TSX:MAG
|
CA |
|
R
|
Rush Enterprises Inc
NASDAQ:RUSHB
|
US |
|
Essity AB (publ)
OTC:ETTYF
|
SE |
|
Z
|
Zurich Insurance Group AG
SWB:ZFIN
|
CH |
|
O
|
Olam International Ltd
F:O5I
|
SG |
|
D
|
Diamondback Energy Inc
SWB:7DB
|
US |
|
T
|
Toronto-Dominion Bank
XMUN:TDB
|
CA |
|
Adidas AG
XETRA:ADS
|
DE |
|
E
|
Equifax Inc
F:EFX
|
US |
|
K
|
Keurig Dr Pepper Inc
DUS:DP5
|
US |
|
A
|
Applied Materials Inc
SWB:AP2
|
US |
|
WWPKG Holdings Company Ltd
HKEX:8069
|
HK |
|
C
|
Columbus McKinnon Corp
XBER:VC3
|
US |
|
F
|
Freeport-McMoRan Inc
F:FPMB
|
US |
|
N
|
Netflix Inc
XMUN:NFC
|
US |
Wall St Price Targets
RV41 Price Targets Summary
Fennec Pharmaceuticals Inc
Fennec Pharmaceuticals Inc
Wall Street analysts forecast RV41 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for RV41 is 16.4 EUR with a low forecast of 13.92 EUR and a high forecast of 20.04 EUR.
Lowest Forecast
Price Target
13.92
EUR
142% Upside
Average Forecast
Price Target
16.4
EUR
185% Upside
Highest Forecast
Price Target
20.04
EUR
248% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RV41's stock price target?
Price Target
16.4
EUR
16.4
EUR
According to Wall Street analysts, the average 1-year price target for RV41 is 16.4 EUR with a low forecast of 13.92 EUR and a high forecast of 20.04 EUR.
What is the Revenue forecast for Fennec Pharmaceuticals Inc?
Projected CAGR
22%
22%
The compound annual growth rate for Revenue over the next 8 years is 22%.
